According to the research report titled ‘Global Research antibody Market Size study with COVID-19 impact, by Product (Reagents and Antibodies), by Technology (Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry and Others), by Application (Proteomics, Drug Development and Genomics), by End user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Contract Research Organizations) and Regional Forecasts 2020-2027’ available with Market Study Report, global research antibody market reflected a valuation of USD 10.52 billion in the year 2019 and is projected to register a robust CAGR of 6.2% during 2020-2027.
 

Factors such as rapid development in neurobiology and stem cell research verticals along with surging demand of antibody detection kits amidst the ongoing COVID-19 pandemic are augmenting the growth of global research antibody market.
 

For the uninitiated, the antibody, which is also known as immunoglobulin, is a protein produced using plasma cells in response to certain antigens. It is primarily used in diagnostics as well as therapeutic procedures for the treatment of various indications such as infectious diseases, cancer, and autoimmune disorder.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2730766/
 

Introduction of numerous antibodies in order to cope up with the rising COVID-19 cases have impelled the demand for research activities in the business sphere, which in turn is positively swaying the global research antibody market dynamics. However, growing concerns regarding the quality of the antibody research are expected to hinder the expansion of the market over the analysis timeframe.
 

Based on product, global research antibody market is split into antibodies and reagents. With regards to technology, the industry is bifurcated into immunohistochemistry, ELISA (enzyme-linked immunosorbent assay), flow cytometry, western blotting, and others.
 

Moving on to the application spectrum, the market comprises of genomics, drug development, and proteomics. Elaborating on the end-user terrain, the industry is fragmented into contract research organizations, academic & research institutes, and biotechnology & pharmaceutical companies.
 

As per the regional analysis of the report, North America accounts for a majority share in global research antibody market and is expected to record significant growth through 2027, owing to rising healthcare expenditure in the region.
 

On the other hand, Asia-Pacific research antibody market is projected to exhibit the highest CAGR during 2020-2027. Factors such as favorable government initiatives which promote antibody research coupled with rising number of COVID-19 cases are providing lucrative opportunities for the growth of the regional market.
 

Leading companies operating in worldwide research antibody market are PerkinElmer, Inc., Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Cell Signaling Technology, Inc (CST), Becton, Dickinson and Company (BD), Merck KGaA, Abcam PLC, and Thermo Fisher Scientific Inc.